Introduction to Part 2 of the Special Issue on Trauma and Substance Misuse

Daniel J. O. Roche,Katherine T. Foster
DOI: https://doi.org/10.1080/15504263.2023.2296005
2024-01-24
Journal of Dual Diagnosis
Abstract:In the first part of our Special Issue focused on the intersection of trauma and substance misuse, we highlighted the complexities of heterogeneity in the etiology and treatment of related comorbidities (Roche & Foster, Citation 2023 ). Specifically, the issue included investigations of heterogeneity related to their co-occurrence, including: (1) what sources and severities of trauma and related reactions modulate substance misuse onset, escalation, and prognosis (Jegede et al., Citation 2023 ; Ferrie et al., Citation 2023 ), (2) what individual-level characteristics and contexts catalyze risk for trauma and substance misuse comorbidity (Beck et al., Citation 2023 Leonard et al. , Citation 2023 , and North & Pfefferbaum Citation 2023 ), (3) who should be screened for substance misuse and when following trauma exposure (North & Pfefferbaum Citation 2023 ), and (4) which treatment integrations and adaptations would be most accessible and beneficial for implementation by which clinicians and for which patients (Ware et al., Citation 2023 ; Vujanovic et al., Citation 2023 )? The second of our two-part Special Issue continues these lines of inquiry and the general themes of the first issue. Here, we present five additional studies addressing (1) person-to-person variation in dynamics between co-occurring post-traumatic stress disorder (PTSD) symptoms and substance misuse in vulnerable subpopulations (Moskal et al., Citation 2024 ) and/or (2) considerations in the length, structure, targets, and outcomes for treatments of trauma symptoms comorbid with substance use disorder (SUD; Balderrama-Durbin et al., Citation 2024 ; Watkins et al., Citation 2024 ; Israel et al., Citation 2024 ; Ralevski et al., Citation 2024 ).
psychiatry,substance abuse,psychology, clinical
What problem does this paper attempt to address?